Published articles & abstracts Archive -

The study of L1 in prostate cancer

Published: 29th November 2016

Dashboard: The study of L1 in prostate cancer

Authors: Pantopikou Katerina, Apostolou Panagiotis, Papasotiriou Ioannis

The role of L1 retrotransposon in circulating tumor cells

Published: 14th October 2016

Dashboard: The role of L1 retrotransposon in circulating tumor cells

Authors: Panagiotis Apostolou, Ioannis Papasotiriou

Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells

Published: 1st September 2016

Dashboard: Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells

Authors: Maria Toloudi, Maria Papadimitriou, Katerina Pantopikou And Ioannis Papasotiriou

The genetic profile of pancreatic circulating tumor cells

Published: 29th June 2016

Dashboard: The genetic profile of pancreatic circulating tumor cells

Authors: Panagiotis Apostolou, Maria Toloudi, Maria Papadimitriou and Ioannis Papasotiriou

Studying the gene expression profile among circulating tumor cells

Published: 3rd June 2016

Link: https://meetinglibrary.asco.org/record/127505/abstract

Authors: Ioannis Papasotiriou, Dimitrios Ntanovasilis, Panagiotis Apostolou.

9-(4-Methoxyquinazolin-2-yl)-9H-purin-6-amine

Published: 19th January 2016

Dashboard: 9-(4-Methoxyquinazolin-2-yl)-9H-purin-6-amine

Authors: Ioanna Vlachou, Eleni Kourtidou and Ioannis Papasotiriou

Find out more about the science behind RGCC tests

Need help?

Can brain tumours also be tested with a blood sample?

No, due to the blood-brain barrier, tumour cells cannot enter the bloodstream. This means that we cannot obtain and isolate any tumour cells from the blood sample.

Is it possible to measure circulating tumour cells (CTC) in patients with lymphoma or leukaemia?

Yes, patients with lymphoma or leukaemia can use an RGCC test to measure the number of circulating tumour cells (CTC) they have.

Which test is the most comprehensive test?

The most comprehensive test is the “Onconomics Plus” test. This provides information on the sensitivity or resistance of the patient’s tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances. The test also contains information about the development of the tumour and its potential by identifying epigenetic tumour markers relevant for the therapy, which are crucial for the correct therapeutic approach.

How do online consultations work?

Online consultations will give you the opportunity to speak to any member of the RGCC Network at a time and place that is convenient to you. You will be able to choose from a shortlist of clinicians who best suit your needs.

Will online consultations take place via Zoom, Skype, or another method?

Your chosen clinician will be in touch to make the arrangements and choose the most convenient method.

Didn't find an answer to your question? Contact us directly.

By loading the map, you agree to Google's privacy policy.
Learn more

Always unblock Google Maps